Subsequently, CARS was identified as a potential immune infiltration-related ferroptosis regulator, whose high expression demonstrated dismal prognosis and positively correlated with PD-L1 expression in ccRCC. Here, CARS1 is linked to nonpapillary renal cell carcinoma.